My PD Story

Brooke Ramsey and his family holding a top fundraising team sign
People with PD

Brooke Ramsey

When I was diagnosed in early 2010, it was a long, long walk back to our car. My wife was with me. We had been told in a matter of a few minutes that based on initial indications, at age 45, "you no doubt have Parkinson's disease (PD)…"  

Little did I realize my life had changed forever from that moment.  

Now, at 61 years young, I recall stepping into that full range of emotions we people with PD all go through: shock, denial, confusion, fear, anger and sadness.  

Looking back, what I really wanted was information that may quickly outline and answer the range of "what now" questions multiplying in my head. What I did not want to do was immediately search the internet and travel down those "rabbit holes" that so often end in false assumptions or conclusions. I found that much of what I came across online was largely irrelevant to my personal situation.  Afterall, I was told very early on that my PD journey would be just that: mine. 

To my surprise, I soon found THE one-stop-shop for everything PD — the Parkinson Foundation website! I quickly realized that THIS was the general guide for the early onset and recently diagnosed that could also lead me to detailed specifics.   

As an added bonus, I found that the Foundation could be a reliable roadmap to forming a PD team of advisers and movement disorders specialists around me. I've nicknamed my group “The B Team."  

I tell them they will become "The A Team" once they find the cure!   

Seriously though, if I have any advice for people who are newly diagnosed, it would be to develop your own “B Team” ASAP. This can include: 

  1. Neurologist and/or Nurse Practitioner, with specialty in Movement Disorders with a focus on PD. 
  2. Neuro Psychiatrist, with experience in treating PD. 
  3. Physical Therapist, with background including PD. 
  4. Physical Trainer.  Exercise is THE #1 activity PD patients can do to help slow down the PD progression. 
  5. Family Practitioner (MD in my case that has experience with PD). 

In 2012, I learned about Moving Day, A Walk for Parkinson’s in Columbus.  For the last 14 years my family, known as Team  Ramsey's Racers, has raised more than $117,000 and has placed first overall of Central Ohio team fundraising in the last several years.  

My wife is my world, and both of my sons, Max and Tyler, are everything to me. I asked my boys if they would like to comment on the "Ramsey PD Story." They replied with this: 

Brooke Ramsey and his family holding a top fundraising team sign at Moving Day

"Our father experiences many symptoms, every day - from difficulty walking, lack of facial expression, to voice and speech problems. Daily activities that most of us take for granted become harder and take longer. 

Loss of balance has become a daily struggle, and our mom says falls are becoming more common. Other symptoms our dad fights include:  tremors, fatigue, anxiety, loss of smell, slowed movement, the urge to “shuffle” when walking, muscle jerks, “brain fog” and sometimes mumbled and quiet speech. 

Even though this list may seem extensive, the one great point that dad repeats to us is he will never let these PD complications define him.  Dad has always been a fighter. Dad recognizes that organizations like the Parkinson’s Foundation need money to help people with Parkinson’s. They are making life better for people with PD. Now, that’s what our local Moving Day family team is all about: fundraising for resources that can help slow the progression of this terrible disease.  

Dad represents these ideals everyday."   

Overall, I am doing well. I now struggle with speech and see a speech therapist after I found that with retirement also comes much less talking, so there are fewer daily benchmarks to test along the way.   

While I don't see myself getting down, I do realize that there is no going back to life before PD. I have a neurodegenerative disease. However, don't mistake these physical indications as me crying in my beer.  

I'm VERY lucky all-around and have MUCH to be thankful for.    

Be Strong. 

Videos & Webinars

Expert Briefing: Managing Nighttime Interruptions in Parkinson's Disease

May 14, 2025

Sleep disturbances are a common and often challenging symptom of Parkinson’s disease (PD). This program explores three prevalent nighttime interruptions—Restless Legs Syndrome (RLS), REM Sleep Behavior Disorder (RBD), and insomnia—that can affect individuals with PD and their care partners. This session will provide an in-depth look at the causes, symptoms, and practical management strategies for these sleep disorders.

Download Slides

Additional Resources

Presenter

Roneil G. Malkani, MD
Associate Professor, Northwestern University Feinberg School of Medicine
Neurologist, Northwestern Memorial Hospital
Specializing in Sleep Medicine and Movement Disorders

My PD Story

Xiaolin (Lindsay) Huang headshot
Researchers

Xiaolin (Lindsay) Huang, PhD

2025 Postdoctoral Fellowship

Exploring the Neurochemistry Behind Parkinson’s-related Sleep Disruption 

The primary impact of Parkinson’s disease (PD) is a progressive loss of neurons in the brain that produce dopamine. Dopamine is a small signaling molecule used by neurons to relay messages and commands important for many tasks, including coordinated movement. As dopamine levels decline over time, the ability to perform these tasks decreases and manifests as PD symptoms. 

It was recently discovered that dopamine likely plays a critical role in regulating sleep. People with PD often experience disrupted sleep as an early symptom of the disease, which significantly impairs health even before movement symptoms begin. Xiaolin (Lindsay) Huang, PhD, a recipient of a Parkinson’s Foundation Postdoctoral Fellowship, is exploring the neurochemistry behind dopamine and sleep, generating new knowledge to guide future therapies that treat PD-associated sleep disruption. 

Research suggests that dopamine is important for waking up and staying awake. However, diminishing dopamine in PD does not lead to chronic sleepiness like this finding would suggest. Dr. Huang, under the mentorship of Yang Dan, PhD, at the University of California, Berkeley, is solving this puzzle by investigating how dopamine signaling coordinates with the “sleep pressure” molecule called adenosine, as well as how dopamine deficits affect a sleep-regulating region of the brain called the medial substantia nigra pars reticulata (mSNr). 

 “By uncovering the neural mechanisms driving PD-associated sleep disturbances, the study will shed light on a critical and underexplored aspect of the disease.” - Dr. Huang 

Dr. Huang working in lab

While dopamine promotes wakefulness, adenosine promotes sleepiness. Adenosine accumulates in the brain throughout the day and eventually overwhelms dopamine levels, leading to growing tiredness until it is time for bed. Using mice with and without simulated PD, Dr. Huang will utilize highly sensitive brain monitoring techniques to observe how PD affects the balance between dopamine and adenosine and how that disruption may impact sleep behaviors. 

Additionally, previous research from Dr. Dan’s lab has revealed that the mSNr region of the brain is important for regulating sleep-wake behaviors. Using the same experimental PD mice, Dr. Huang will assess if and how dopamine loss impairs neuron activity in the mSNr region, further disrupting sleep patterns in those animals. 

Altogether, these investigations into how PD-related sleep disruption are related to adenosine levels and mSNr changes can lead to future research and treatment development addressing this debilitating non-movement PD symptom. When asked what this award means for her work and career in PD research, Dr. Huang said “Receiving the Parkinson’s Foundation Postdoctoral Fellowship is both an honor and a pivotal step in my scientific journey. Ultimately, the findings may inform the development of new therapies to improve sleep and enhance quality of life for people living with PD.” 

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers. 

My PD Story

Pam Marcott Headshot
Researchers

Pam Marcott, MD, PhD

2025 Postdoctoral Fellowship

Reclaiming Restful Sleep by Unraveling How Parkinson’s Changes the Brain 

Along with the typical movement-related symptoms, many people with Parkinson’s disease (PD) also experience other non-movement health issues. These non-movement symptoms can be quite debilitating and sometimes more difficult to notice by care partners. 

One common non-movement PD symptom is difficulty sleeping, often in the form of waking up frequently throughout the night. Pamela Marcott, MD, PhD, a recipient of a Parkinson’s Foundation Postdoctoral Fellowship, is casting a spotlight on the sleep-associated circuits of the brain to understand how exactly PD impacts sleep patterns. By uncovering the mechanisms behind PD-related sleep problems, she hopes to help advance new therapies for such disturbances. 

While much of the neuroscience of sleep is still a mystery, researchers do know that staying asleep through the night requires a highly calibrated balance of different signals in the brain. These sleep signals are relayed through brain cells called neurons and can vary in frequency and intensity, depending on their purpose. If these signals become altered and imbalanced, sleep fragmentation occurs with "frequent changes between different sleep and wake states, leading to less consolidated and restful sleep,” said Dr. Marcott. 

Under the mentorship of Alexandra Nelson, MD, PhD, and Ying-Hui Fu, PhD, at the University of California, San Francisco, a Parkinson’s Foundation Center of Excellence, Dr. Marcott is investigating how PD changes the behavior of neurons in a specific sleep-regulating region of the brain called the pedunculopontine nucleus (PPN). PPN neurons act like telephone operators, relaying important signals across the brain. Using mice with and without PD-like symptoms, she will measure how the disease affects the ability of PPN neurons to transmit their important sleep signals. 

“Results of this study will improve our understanding of the circuit mechanisms that regulate sleep disturbances in PD, which will inform future therapeutic treatments.” - Dr. Marcott 

After learning more about how PD changes the sleep-related neurons’ signaling ability, Dr. Marcott will then monitor the brains of the mice as they sleep. She will keep a close eye on how the PPN neurons activate during sleep phase transitions, as she believes PD causes these neurons to be overactive and lead to fragmented sleep. Observing in real time how PD alters sleep regulation in the brain will provide a strong foundation for understanding how to treat this symptom and give restful nights back to people with PD. 

 “As a physician scientist in this space I am committed to making meaningful discoveries in the laboratory that will benefit my patients, and I am excited to have the opportunity to start this phase of my career with the support of the Parkinson's Foundation,” said Dr. Marcott. 

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers. 

Advancing Research

Meet a Researcher Exploring Parkinson’s-related Sleep Disruption

Meet Xiaolin Huang

The primary impact of Parkinson’s disease (PD) is a progressive loss of neurons in the brain that produce dopamine. Dopamine is a small signaling molecule used by neurons to relay messages and commands important for many tasks, including coordinated movement. As dopamine levels decline over time, the ability to perform these tasks decreases and manifests as PD symptoms.

It was recently discovered that dopamine likely plays a critical role in regulating sleep. People with PD often experience disrupted sleep as an early symptom of the disease, which significantly impairs health even before movement symptoms begin. Xiaolin (Lindsay) Huang, PhD, a recipient of a Parkinson’s Foundation Postdoctoral Fellowship, is exploring the neurochemistry behind dopamine and sleep, generating new knowledge to guide future therapies that treat PD-associated sleep disruption.

“As a neuroscientist, my long-term goal is to understand why people with Parkinson’s disease (PD) often have trouble sleeping and to find ways to help,” said Dr. Huang. “This interest was shaped by my research experience during college, graduate school and early postdoctoral training. Now, I use state-of-the-art tools to study how brain circuits that control sleep are affected in PD.”

Research suggests that dopamine is important for waking up and staying awake. However, diminishing dopamine in PD does not lead to chronic sleepiness like this finding would suggest. Dr. Huang, under the mentorship of Yang Dan, PhD, at the University of California, Berkeley, is solving this puzzle by investigating how dopamine signaling coordinates with the “sleep pressure” molecule called adenosine, as well as how dopamine deficits affect a sleep-regulating region of the brain called the medial substantia nigra pars reticulata (mSNr).

“By uncovering the neural mechanisms driving PD-associated sleep disturbances, the study will shed light on a critical and underexplored aspect of the disease,” said Dr. Huang.

While dopamine promotes wakefulness, adenosine promotes sleepiness. Adenosine accumulates in the brain throughout the day and eventually overwhelms dopamine levels, leading to growing tiredness until it is time for bed. Using mice with and without simulated PD, Dr. Huang will utilize highly sensitive brain monitoring techniques to observe how PD affects the balance between dopamine and adenosine and how that disruption may impact sleep behaviors.

Additionally, previous research from Dr. Dan’s lab has revealed that the mSNr region of the brain is important for regulating sleep-wake behaviors. Using the same experimental PD mice, Dr. Huang will assess if and how dopamine loss impairs neuron activity in the mSNr region, further disrupting sleep patterns in those animals.

These investigations into how PD-related sleep disruption are related to adenosine levels and mSNr changes can lead to future research and treatment development addressing this debilitating non-movement symptom.

“Receiving this award is both an honor and a pivotal step in my scientific journey,” said Dr. Huang. “It provides essential support for me to pursue an exciting project aimed at uncovering novel mechanisms underlying sleep disturbances in Parkinson’s disease. With the Foundation’s backing, I will actively engage with the broader PD research community through symposia and seminars, fostering meaningful collaborations and broadening my perspective on the field. This fellowship marks a critical milestone toward my long-term goal of establishing an independent research lab focused on understanding and treating sleep deficits in PD at the circuit and systems level.”

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers.

My PD Story

Laura de Lima Xavier headshot
Researchers

Laura de Lima Xavier, MD

2025 Clinical Research Training Scholarship in Parkinson’s Disease

Using Brain Scans to Understand what Causes Parkinson’s-related Dystonia

Many people with Parkinson’s disease (PD) experience dystonia — sustained or repetitive muscle twitching, spasms or cramping that can occur in different parts of the body. These involuntary movements are often more forceful and painful than those of dyskinesia, a potential side effect of some PD medications that are involuntary, erratic movements that can either be fluid, rapid or extended muscle spasms.

Developing effective treatments for PD-related dystonia is difficult because we don’t know a lot about the neuroscience behind the condition. Laura de Lima Xavier, MD, recipient of the 2025 Clinical Research Training Scholarship in Parkinson’s Disease funded by the Parkinson’s Foundation and the American Brain Foundation, in collaboration with the American Academy of Neurology, is comparing brain scans of people with PD with and without dystonia to identify the key brain regions involved in dystonia to search for better therapeutic options.

“These efforts aim to significantly improve diagnostic tools, treatment strategies, and overall quality of life for individuals suffering from PD-related dystonia,” said Dr. Xavier.

Working as a neurologist and movement disorders fellow at Washington University in St. Louis, MO, Dr. Xavier believes that the key to understanding PD-associated dystonia lies with resting state functional MRI (rs-fMRI) scanning. This technology highlights how different regions of the brain are connected, and has already been used to better understand isolated dystonia in people without PD.

Dr. Xavier will compare rs-fMRI data that was previously collected from people in the PD community with and without dystonia, focusing on the sensorimotor network (SMN) area of the brain responsible for coordinating movement.

Identifying which regions in the SMN activate differently in people with dystonia could lead to future treatments that target those regions and alleviate the symptom.

“Future research will include examining different types of PD-related dystonia and using these insights to develop better treatment options,” said Dr. Xavier.

Dr. Xavier is grateful for the support she received to make this research possible and is optimistic about its potential to make a difference for people with PD.

“At a time when funding is scarce and the demand for clinicians and scientists trained in movement disorders is increasing, this support is invaluable. It provides me with the resources necessary to delve deeply into the mechanisms of PD-related dystonia, ultimately driving improvements in clinical care for those affected by Parkinson's.” - Dr. Xavier.

Meet more Parkinson’s researchers! Explore our My PD Stories featuring PD researchers.

Tips for Daily Living

Cómo abordar los trastornos del sueño en el Parkinson para un sueño más profundo

Man laying in bed having trouble sleeping

Dormir bien no sólo es importante para la función cerebral; es esencial para el bienestar de todo el cuerpo. El sueño favorece la salud cardiaca e intestinal, la función inmunitaria y más. Los trastornos del sueño pueden ser frecuentes en la enfermedad de Parkinson (EP), pero dormir bien es posible. Descubra cómo identificar y controlar los síntomas del insomnio, el síndrome de las piernas inquietas (SPI) y el trastorno de la conducta del sueño REM (RBD, por sus siglas en inglés).

El siguiente artículo se basa en una Charla con expertos de la Parkinson's Foundation acerca del manejo de los trastornos del sueño, presentada por el Dr. Roneil G. Malkani, profesor asociado de la Feinberg School of Medicine de Northwestern University y neurólogo del Northwestern Memorial Hospital, un Centro de Excelencia de la Parkinson’s Foundation.

Aunque se supone que las personas pasan alrededor de un tercio del día durmiendo, los cambios cerebrales relacionados con el Parkinson y los síntomas de la enfermedad pueden alterar el reloj interno del cuerpo.

Estos desafíos, junto con un exceso de somnolencia diurna, pueden crear un círculo vicioso. Dormir demasiado durante el día e interrupciones del sueño por la noche pueden causar fatiga e impactar en el movimiento, las funciones, el estado de ánimo y el bienestar.

Afrontar el insomnio

Al igual que la buena salud, el sueño reparador implica esfuerzo, a menudo requiriendo ejercicio diario y tiempo al aire libre con luz natural. Limitar las siestas, relajarse antes de acostarse, reducir al mínimo el tiempo frente a las pantallas, respetar un horario para acostarse y mantener el dormitorio oscuro y fresco también son esenciales para un sueño profundo. A veces, el simple hecho de salir de la cama cuando se siente inquieto para realizar una actividad tranquila hasta que se sienta cansado puede marcar la diferencia.

Sin embargo, incluso cuando se siguen las mejores prácticas para dormir, el insomnio puede persistir en el Parkinson:

  • A medida que se desgasta la levodopa, pueden aumentar el temblor u otros síntomas motores, dificultando el darse la vuelta en la cama.

  • Los dolores relacionados con la edad o la artritis también pueden agudizarse por la noche.

  • La nicturia (la necesidad de orinar con frecuencia durante la noche) puede afectar hasta a un 60% de las personas con la EP. El agrandamiento de la próstata también puede aumentar la urgencia urinaria en los hombres.

  • La depresión y la ansiedad, frecuentes y a menudo subtratadas en las personas con la EP, pueden exacerbar el insomnio. También el estrés. Por el contrario, el insomnio puede provocar cambios de humor y estrés.

  • La apnea del sueño (la interrupción de la respiración al dormir) puede afectar a casi la mitad de las personas con la EP.

Si sigue dando vueltas en la cama a pesar de dormir en un entorno saludable, hable con su médico, quien puede revisar y ajustar la dosis y el horario de los medicamentos actuales y llegar a la raíz de los problemas de sueño. Las herramientas utilizadas para diagnosticar los trastornos del sueño suelen incluir su historial médico, un diario del sueño o un estudio del sueño.

El tratamiento del insomnio debe personalizarse en función de sus necesidades y síntomas individuales y puede incluir:

  • Terapia cognitivo-conductual (TCC): estrategias aprendidas en persona o en línea diseñadas para abordar los comportamientos y pensamientos que impiden dormir bien.

  • Técnicas de relajación aprendidas, como la relajación muscular progresiva, la repetición silenciosa de ciertas palabras o frases tranquilizadoras (entrenamiento autógeno) o el uso de la visualización mental positiva (imaginería guiada).

  • Restricción del sueño, que inicialmente limita el tiempo en la cama con el objetivo de promover un sueño más largo y profundo.

  • Terapia de luz brillante para disminuir la somnolencia diurna.

Su médico puede combinar la terapia del sueño con medicación. Entre los medicamentos habituales para el insomnio están:

  • Melatonina

  • Hipnóticos z (zolpidem, eszopiclona y zaleplon) y benzodiacepinas (clonazepam y temazepam), que favorecen el sueño.

  • Terapias inhibidoras de la vigilia como trazadona, antidepresivos tricíclicos (amitriptilina y doxepina), mirtazapina, antagonistas de la orexina (suvorexant, lemborexant y daridorexant), melatonérgicos (melatonina y ramelteon) y quetiapina

Otras terapias para el insomnio relacionado con la EP pueden ser la safinamida, la doxepina y la eszopiclona.

Síndrome de las piernas inquietas (SPI)

Las personas con la enfermedad de Willis-Ekbom, comúnmente conocida como síndrome de las piernas inquietas, pueden sentir una incómoda necesidad de moverse, así como hormigueo, ardor, dolor o sensación de que algo le camina por las piernas. Aunque no siempre hay una causa conocida, el SPI puede estar relacionado con alteraciones neurológicas, medicamentos, incluidos algunos antidepresivos o carencia de hierro. Cuando se sospecha el SPI con base en los síntomas de una persona, es necesario evaluar los niveles de hierro.

Los tratamientos para la deficiencia de hierro incluyen el hierro oral o intravenoso. Si los niveles de hierro son suficientes y los síntomas persisten, existen otras opciones de tratamiento:

  • Ligandos alfa-2-delta: gabapentina, pregabalina y gabapentina enacarbil.

  • Benzodiacepinas, incluido el clonazepam.

  • Medicamentos como el dipiridamol o la amantadina o, en casos graves, opiáceos.

La activación motora tónica (TOMAC) es un nuevo tratamiento de estimulación nerviosa por debajo de la rodilla, aprobado por la Food and Drug Administration de los EE.UU. para el SPI moderado a severo, que puede utilizarse periódicamente a lo largo del día.

Aunque existe una fuerte relación entre el Parkinson y el SPI, los investigadores están descubriendo que las causas subyacentes de cada enfermedad pueden ser muy diferentes. El Parkinson está relacionado con la pérdida de dopamina en el mesencéfalo, mientras que el SPI parece estar ligado a cambios de señalización en otras zonas del cerebro.

Los fármacos dopaminérgicos utilizados habitualmente para la EP también fueron en su momento uno de los pilares del tratamiento del SPI. Ahora se ha demostrado que el uso prolongado de medicamentos dopaminérgicos en personas con SPI a veces puede empeorar la señalización cerebral y los síntomas del SPI. En alguien con Parkinson, una cuidadosa adaptación de los medicamentos dopaminérgicos utilizados para controlar los síntomas motores también puede ser eficaz para controlar los síntomas del SPI.

Trastorno conductual del sueño REM (RBD)

Durante la fase de movimientos oculares rápidos (REM, por sus siglas en inglés) del sueño, cuando se sueña, normalmente sólo se mueven los ojos. El cerebro bloquea los movimientos grandes del cuerpo como medida de protección. Las enfermedades neurodegenerativas, incluido el Parkinson, están relacionadas con el trastorno conductual del sueño REM (RBD, por sus siglas en inglés), un fallo de este interruptor de encendido y apagado. La apnea del sueño y el consumo de antidepresivos también pueden estar relacionados con el RBD.

El RBD puede hacer que una persona actúe físicamente sus sueños. La persona puede hablar en sueños, utilizar un lenguaje agresivo o gritar, caerse o saltar de la cama. Estos sueños vívidos pueden ser leve o increíblemente perturbadores y pueden causar lesiones al soñador o a su compañero de cama.

Casi un 50% de las personas con Parkinson presentan síntomas de trastorno conductual del sueño REM, que pueden aparecer varios años antes del diagnóstico de Parkinson.

Crear un entorno seguro para dormir es esencial para quien experimenta síntomas de RBD:

  • Retire cualquier objeto que suponga un riesgo de lesión.

  • Si es posible, baje el colchón para reducir el riesgo de caídas.

  • Coloque cojines protectores en las esquinas de los muebles cerca de la cama.

  • Añade acolchado a la cabecera, una barandilla a la cama para evitar caídas y una alfombra o tapete junto a la cama para amortiguar las caídas accidentales.

Los compañeros de cama pueden conseguir un sueño más profundo utilizando una barrera de almohadas o durmiendo en otra cama.

Un estudio del sueño puede diagnosticar o descartar el RBD y a menudo se utilizan medicamentos para controlar los síntomas. Los tratamientos pueden incluir:

  • Melatonina (de 3 a 12 miligramos)

  • Clonazepam (de 0.25 a 2 miligramos antes de acostarse) o pramipexol

  • Rivastigmina transdérmica

Aprenda más

Explore nuestros recursos acerca del sueño en el Parkinson: 

My PD Story

Cecilia smiling brightly next to a bouquet of flowers at what appears to be a formal event.
People with PD

Cecelia LaValle

Ceceilia LaValle’s family and friends knew her as the life of any party — an entrepreneur, a great artist, a wonderful cook, a devoted sister, wife and mother.

“She was an integral figure in our family and had so much enthusiasm for life,” said Neilia LaValle, one of Ceceilia’s younger sisters.

When Cecelia was diagnosed with Parkinson’s disease (PD) in the early 1990s after noticing rigidity in her left arm, she leaned into her passions and was determined to live life to the fullest as she bravely fought PD.

She had already been diagnosed with PD by the time she met her fourth husband, and ultimate care partner, Jimmie Amox, while they were enrolled as graduate students at Louisiana Tech University. Though she made several careers for herself, art always drew her back in.

“Her art really blossomed during her graduate studies,” said Deanna LaValle High, one of Ceceilia’s younger sisters. “I would say that Cecelia was at the peak of her artistic capability and showing every sign of continuing to grow as an artist, when she was diagnosed with Parkinson's. She continued to make art until the disease finally robbed her of that ability.”

Cecelia’s family rallied around her, researching PD and supporting her as she explored treatment options. Jimmie said she was determined to continue living her life and was invested in finding PD care that allowed her to do so. She consulted with several doctors around the world and tried many treatments to alleviate her symptoms, including the hallucinations.

“I lost my mom long before she passed away, due to the hallucinations,” said Michele Smith, Cecelia’s daughter. “It was difficult for our family to watch her deteriorate.”

Before Cecelia passed away in 2016, Neilia spoke to a friend who had recently started her own non-profit to raise money for breast cancer, which inspired Neilia to do the same and support a cause near to her heart — Parkinson’s disease.

“Seeing what my sister was going through made me want to help find a cure for Parkinson’s,” Neilia said. “I don’t want other people to go through what my family and my sister went through.”

Neilia uses her foundation to support organizations like the Parkinson’s Foundation that are working to find a cure for PD. She’s proud to honor her sister and to continue her fight for a cure.

“It seems like more and more people are directly impacted by Parkinson’s. We need to get more people actively involved in supporting organizations that are looking for a cure, like the Parkinson’s Foundation. There is hope, and that is what we need to use to keep us going.”
- Neilia LaValle

Like Neilia, other members of Cecelia’s family are inspired by the Parkinson’s Foundation and happy to see more resources for people with Parkinson’s, care partners and their families.

“Many of the current treatments and resources available now were not available when Cecelia was diagnosed,” said Jimmie. “Organizations like the Parkinson’s Foundation have changed that. If I could offer advice to those newly diagnosed with Parkinson's disease or people entering the Parkinson's care partner world, I would say that the first thing you need in your toolbox is love for each other. Grow that love every day. Get to truly know each other and constantly question reactions to new experiences with this disease.”

“If you are new to Parkinson’s, take stock of yourself and your priorities,” said Deanna. “And, if you are inclined to live life fully like Cecelia, do it, do it, do it. As best you can.”

With your support, we can invest in research that will help us find new treatments and a cure for Parkinson’s in years, not decades. To make a donation, visit Parkinson.org/Donate.

My PD Story

DawnElla Rust out in nature smiling at the camera.
People with PD

DawnElla Rust

My name is DawnElla Rust, and basketball was my first love. Though not a top-tier player like Caitlin Clark, I earned a scholarship for three years in college. I enjoyed training and knew my body well. After basketball, I stayed active with running, walking, weightlifting, hiking and rafting, while earning a Doctor of Education in Health Promotions and working as a university professor. My third love was teaching health in higher education, with my second love being my marriage in 1990.

In 2010, I became interim chair of my department, a role I hated and which brought significant stress. Notable stress symptoms included my right arm not swinging when I walked, difficulty fastening seat belts, lack of blinking, hand tremors, an unexplained Achilles issue and increased anxiety. The body that I knew well was not working. Collectively, these symptoms led to a Parkinson's disease (PD) diagnosis, which shocked me.

I knew nothing about Parkinson’s. Naively I even told a friend “Give me a couple of weeks and I will have this Parkinson’s thing figured out.” Initially, I believed I could quickly manage Parkinson's, but 15 years later, “I’m still figuring it out.”

I am better today thanks to invaluable resources from the Parkinson’s Foundation. One valuable resource is their trained professionals who offer phone support, especially on difficult days — and there are difficult days. I often use these Parkinson’s Foundation resources in an educational approach to openly discuss my diagnosis, because a teacher always teaches!

We’re here for you.
For answers to your Parkinson’s questions, call or email our Helpline. 1-800-4PD-INFO (1-800-473-4636)

As a university health professor, I was able to educate others on managing chronic diseases such as Parkinson’s disease. I taught a course on Social and Emotional Health, emphasizing the impact of social connections and emotions on physical well-being. The Parkinson’s Foundation's mission, "Better Lives. Together.", aligns with the principles I have taught and lived by.

Teaching concepts related to happiness, gratitude, humor and awe has empowered me to maintain a positive quality of life despite my diagnosis. Student feedback indicated that my personal narrative significantly contributed to their understanding of living well.

The health philosophy I advocate for is one where individuals strive to live well in the face of illness, disability and trauma.

Life inevitably presents challenges, such as the loss of loved ones, catastrophic events and diagnoses like Parkinson’s. I retired in 2024 after 30 years in higher education due to non-movement symptoms affecting my teaching, but I continue to educate and live a fulfilling life in retirement.

Explore helpful Parkinson’s resources and browse by topic, from mental wellness and treatments to fitness and diet.

Raise Awareness

How to Address Sleep Disorders in Parkinson’s for Sounder Slumber

Man struggling to sleep

Good sleep is not just important for brain function – it is essential for whole-body well-being. Sleep fuels heart and gut health, immune function and more. Sleep disturbances can be common in Parkinson’s disease (PD), but getting a good night’s sleep is possible. Discover how to identify and manage symptoms of insomnia, restless leg syndrome (RLS) and REM sleep behavior disorder (RBD).

The following article is based on a Parkinson’s Foundation Expert Briefing about managing sleep disturbances, hosted by Roneil G. Malkani, MD, associate professor, Northwestern University Feinberg School of Medicine, and neurologist, Northwestern Memorial Hospital, a Parkinson’s Foundation Center of Excellence.

While people are meant to spend about a third of their day sleeping, Parkinson’s-related brain changes and disease symptoms can disrupt the body’s internal clock.

These challenges, coupled with excess daytime sleepiness, can create a vicious cycle. Too much sleep during the day and fragmented sleep at night can cause fatigue and impact movement, function, mood and well-being.

Tackling Insomnia

Like good health, restful slumber takes work, often requiring daily exercise and time outside in natural daylight. Limiting naps, winding down before bed, minimizing screentime, sticking to a bedtime schedule and keeping a dark, cool bedroom are also key to deep sleep. Sometimes, just stepping out of bed when feeling restless to pursue a quiet activity until feeling tired can make all the difference.

However, even when following best practices for sleep, insomnia can persist in Parkinson’s:

  • As levodopa wears off, tremor or other movement symptoms can increase, making turning over in bed difficult.

  • Age-related aches or arthritis can also flare up at night.

  • Nocturia, the need to frequently urinate throughout the night, can affect as many as 60% of people with PD. An enlarged prostate can also increase urinary urgency for men.

  • Depression and anxiety, common and often undertreated in people with PD, can exacerbate sleeplessness. So can stress. Conversely, insomnia can cause mood changes and stress.

  • Sleep apnea, disrupted breathing during sleep, can impact nearly half of people with PD.

If tossing and turning continue despite a healthy sleeping environment, talk to your doctor, who can review and adjust the dosage and timing of current medications and get to the root of sleep problems. Tools used to diagnose sleep disorders often include your medical history, a sleep journal or a sleep study.

Insomnia treatment should be personalized to your individual needs and symptoms, and might include:

  • Cognitive behavioral therapy (CBT), strategies learned in person or online designed to tackle behaviors and thinking that interfere with good sleep.

  • Learned relaxation techniques, such as progressive muscle relaxation, silent repetition of certain calming words or phrases (autogenic training) or use of positive mental visualization (guided imagery).

  • Sleep restriction, which initially limits time in bed with the aim of promoting longer, deeper sleep.

  • Bright light therapy to lessen daytime sleepiness.

Your doctor might combine sleep therapy with medication. Common insomnia medications include:

  • Melatonin

  • Sleep-promoting z-hypnotics (zolpidem, eszopiclone and zaleplon) and benzodiazepines (clonazepam and temazepam)

  • Wakefulness-inhibiting therapies including trazadone, tricyclic antidepressants (amitriptyline and doxepin), mirtazapine, orexin antagonists (suvorexant, lemborexant and daridorexant), melatonergics (melatonin and ramelteon) and quetiapine

Other PD-related insomnia therapies can include safinamide, doxepin and eszopiclone.

Restless Leg Syndrome (RLS)

People who experience Willis-Ekbom disease, commonly known as restless leg syndrome, can feel an uncomfortable urge to move, as well as tingling, burning, aching or crawling sensations in the legs. While there isn’t always a known cause, RLS can be linked to neurological changes, medications, including some antidepressants, or iron deficiency. When RLS is suspected, based on a person’s symptoms, evaluating iron levels is necessary.

Treatments for iron deficiency include oral or intravenous iron. If iron levels are sufficient and symptoms continue, there are other treatment options available, including:

  • Alpha-2-delta ligands – gabapentin, pregabalin and gabapentin enacarbil.

  • Benzodiazepines, including clonazepam.

  • Medications such as dipyridamole or amantadine or in severe cases, opioids.

Tonic motor activation (TOMAC) is a new, below-the-knee nerve stimulation treatment approved by the U.S. Food and Drug Administration for moderate to severe RLS that can be used periodically throughout the day.

Though there is a strong relationship between Parkinson’s and RLS, researchers are discovering that the underlying causes of each disease may be very different. Parkinson's is connected to midbrain dopamine loss, while RLS seems to be linked to signaling changes in other areas of the brain.

Dopamine medications commonly used for PD were also once a mainstay RLS treatment. Evidence now shows long-term use of dopamine medications in people with RLS can sometimes cause brain signaling and RLS symptoms to worsen. In someone with Parkinson’s, careful tailoring of dopamine medications used to manage movement symptoms can also be effective in managing RLS symptoms.

REM Sleep Behavior Disorder (RBD)

During the rapid eye movement (REM) stage of sleep, when dreaming happens, typically only the eyes move. The brain shuts down large-body movement as a protective measure. Neurodegenerative diseases, including Parkinson’s, are linked to REM sleep behavior disorder (RBD) failure of this on-off switch. Sleep apnea and antidepressant use can also be linked to RBD.

RBD can cause someone to physically act out their dreams. A person might talk in their sleep, use harsh language or scream, or fall or jump out of bed. These vivid dreams can be mild or incredibly disruptive and may cause injury to the dreamer or their bed partner.

Nearly 50% of people with Parkinson’s report REM sleep behavior disorder symptoms, which can precede a Parkinson’s diagnosis by several years.

Creating a safe sleeping environment is essential for someone experiencing RBD symptoms:

  • Remove any objects that present a risk for injury.

  • If possible, lower the mattress to reduce fall risk.

  • Place protective cushioning on the corners of bedside furniture.

  • Add cushioning to the headboard, a bedrail to prevent falls and a mat or carpet beside the bed to cushion accidental falls.

Bed partners may get deeper sleep using a pillow barrier or separate bed.

A sleep study can diagnose or rule out RBD and medications are often used to manage symptoms. Treatments may include:

  • Melatonin (3 to 12 milligrams)

  • Clonazepam (.25 to 2 milligrams at bedtime) or pramipexole

  • Transdermal rivastigmine

Learn More

Explore our resources about sleep in Parkinson’s: 

Back to Top